CRH plc
NYSE:CRHConstruction Materials
+$2.35 today
- Market cap
- $61.59B
- Beta
- 1.19
- P/E (TTM)
- 14.8
- EPS (TTM)
- $7.56
- Dividend yield
- 1.36%
Volume 4.49M
Average 4.91M
CRH EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
CRH plcNYSE: CRH
EBITDA · Q2 FY2026 · quarter ended Jun 2026
EBITDA growth accelerates
Q2 FY2026 EBITDA of $3.51B rose 41.2% year over year, ahead of the +23.6% change in trailing-twelve-month EBITDA. Sequentially, it rose 531.9% from the prior quarter. Over 3 fiscal years it compounded at +11.4% a year.
Context
- EBITDA amounted to 20.8% of revenue in FY2025, up 0.7 pp from a year earlier.
- EBITDA increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 3 analysts of $7.25B (-6.7%) for the fiscal year ending Dec 2026, a slowdown from the +9.1% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $3.51B+531.9% QoQ
- Last fiscal yearDec 2025
- $7.77B+9.1% YoY
- LTMJun 2026
- $8.82B+23.6% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +41.2% | -77.7% | -118.9 pp |
| 1 year | +9.1% | -6.7% | -15.8 pp |
| 3-year CAGR | +11.4% | +4.4% | -7.0 pp |
| 5-year CAGR | +5.2% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 7.77B USD
- Year-over-year change
- +9.1%
- 4-year CAGR
- +9.4%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 7.77B | +9.1% |
| FY2024 | 2024-12-31 | 7.12B | +18.6% |
| FY2023 | 2023-12-31 | 6.01B | +6.7% |
| FY2022 | 2022-12-31 | 5.63B | +3.9% |
| FY2021 | 2021-12-31 | 5.42B | — |
EBITDA vs competitors
How CRH compares with its peers on the latest reported figures
- CRH's LTM Jun 2026 EBITDA of $8.82B is the highest of the 6 companies compared; the peer median is $2.08B.
- Its year-over-year change of +23.6% is the highest of 6, against a peer median of +1.3%.
- EBITDA amounts to 22.8% of revenue for CRH, versus a peer median of 31.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $8.82B | +23.6% | +11.4% | 22.8% | |
| LTM Jun 2026 | $2.8B | +1.3% | +5.8% | 16.5% | |
| LTM Jun 2026 | $2.56B | +19.5% | +19.0% | 31.5% | |
| LTM Jun 2026 | $2.08B | -5.0% | +7.0% | 31.2% | |
| LTM Jun 2026 | $741.67M | -5.3% | +0.1% | 31.9% | |
| LTM Jun 2026 | $553.1M | +22.9% | +4.6% | 20.2% | |
| Peer median (excluding CRH) | $2.08B | +1.3% | +5.8% | 31.2% | |
Competitors are the stored peer set for CRH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 30.98B | 32.72B | 34.95B | 35.57B | 37.45B |
| Cost of Revenue | 20.49B | 21.84B | 22.99B | 22.87B | 23.92B |
| Gross Profit | 10.49B | 10.88B | 11.96B | 12.7B | 13.53B |
| Gross Margin | 33.9% | 33.2% | 34.2% | 35.7% | 36.1% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 6.9B | 6.99B | 7.49B | 7.85B | 8.28B |
| Operating Expenses | 6.9B | 6.99B | 7.78B | 7.78B | 8.09B |
| Depreciation & Amortization | 1.77B | 1.76B | 1.63B | 1.8B | 2.16B |
| EBITDA | 5.42B | 5.63B | 6.01B | 7.12B | 7.77B |
| EBITDA Margin | 17.5% | 17.2% | 17.2% | 20.0% | 20.8% |
| Operating Income | 3.59B | 3.89B | 4.19B | 4.93B | 5.44B |
| Operating Margin | 11.6% | 11.9% | 12.0% | 13.8% | 14.5% |
| Interest Income | 0 | 65M | 206M | 143M | 146M |
| Interest Expense | 311M | 401M | 376M | 612M | 810M |
| Other Income / Expenses | (243M) | (425M) | (189M) | (211M) | (635M) |
| Income Before Tax | 3.34B | 3.47B | 4B | 4.71B | 4.81B |
| Pre-Tax Margin | 10.8% | 10.6% | 11.4% | 13.3% | 12.8% |
| Income Tax Expense | 721M | 785M | 925M | 1.09B | 1.04B |
| Net Income | 2.57B | 3.85B | 3.18B | 3.49B | 3.75B |
| Net Margin | 8.3% | 11.8% | 9.1% | 9.8% | 10.0% |
| EPS (Basic) | 3.29 | 5.07 | 4.36 | 5.06 | 5.54 |
| EPS (Diluted) | 3.26 | 5.03 | 4.33 | 5.02 | 5.51 |
| Weighted Avg Shares | 780.2M | 758.3M | 723.9M | 683.3M | 673.2M |
| Weighted Avg Shares (Diluted) | 786.8M | 764.1M | 729.2M | 689.5M | 677M |
CRH plc
NYSE:CRH
Intrinsic Alpha fair value
Locked
Current Price
$92.58
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.